Acceptability of hypertension screening in pharmacies participating in May Measurement Month.
作者信息
Gysel Stephanie C, Tsuyuki Ross T
机构信息
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB.
出版信息
Can Pharm J (Ott). 2025 Jan 8;158(2):81-82. doi: 10.1177/17151635241306138. eCollection 2025 Mar-Apr.
Abstract
摘要
相似文献
1
Acceptability of hypertension screening in pharmacies participating in May Measurement Month.参与五月测量月活动的药房中高血压筛查的可接受性。
Can Pharm J (Ott). 2025 Jan 8;158(2):81-82. doi: 10.1177/17151635241306138. eCollection 2025 Mar-Apr.
2
Stakeholders' Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review.利益相关者对社区药店药剂师主导筛查的可接受性：系统评价。
Am J Prev Med. 2022 Oct;63(4):636-646. doi: 10.1016/j.amepre.2022.04.023. Epub 2022 Jun 7.
3
High blood pressure screening in pharmacies during May Measurement Month campaigns in Switzerland.瑞士“五月测量月”活动期间，药店中的高血压筛查。
Blood Press. 2022 Dec;31(1):129-138. doi: 10.1080/08037051.2022.2086531.
4
[Blood pressure measurement campaign (May Measurement Month) from community pharmacies in 2018: analysis of screening in Spain].2018年社区药房血压测量活动（五月测量月）：西班牙筛查情况分析
Hipertens Riesgo Vasc. 2021 Jul-Sep;38(3):109-118. doi: 10.1016/j.hipert.2021.02.007. Epub 2021 Apr 15.
5
Chlamydia screening interventions from community pharmacies: a systematic review.社区药房的衣原体筛查干预措施：一项系统综述。
Sex Health. 2013 Jul;10(3):229-39. doi: 10.1071/SH12069.
6
Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.社区药店丙型肝炎病毒筛查：瑞士试点可行性研究结果。
BMC Infect Dis. 2023 Jun 7;23(1):384. doi: 10.1186/s12879-023-08362-1.
7
The feasibility and acceptability of screening for hypertension in private drug retail outlets: a pilot study in Mwanza region, Tanzania.在坦桑尼亚姆万扎地区的私营药店筛查高血压的可行性和可接受性：一项试点研究
Int Health. 2016 Sep;8(5):360-6. doi: 10.1093/inthealth/ihw023. Epub 2016 May 11.
8
Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.在社区药房筛查病前代谢综合征：一项横断面描述性研究。
BMC Public Health. 2014 May 22;14:487. doi: 10.1186/1471-2458-14-487.
9
May Measurement Month 2019: an analysis of blood pressure screening results from India.2019年5月测量月：印度血压筛查结果分析
Eur Heart J Suppl. 2021 May 20;23(Suppl B):B73-B76. doi: 10.1093/eurheartj/suab047. eCollection 2021 May.
10
Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet Nam.评估越南胡志明市零售药店结核病筛查的新型参与机制、筛查率及可接受性。
PLOS Glob Public Health. 2022 Oct 17;2(10):e0000257. doi: 10.1371/journal.pgph.0000257. eCollection 2022.
引用本文的文献
1
A hyper-opportunity for pharmacy.药房的一个超级机遇。
Can Pharm J (Ott). 2025 May 29:17151635251342414. doi: 10.1177/17151635251342414.
本文引用的文献
1
Community pharmacy-based hypertension screening: May Measurement Month 2023 in 3 Canadian provinces.基于社区药房的高血压筛查：2023年5月测量月在加拿大3个省份开展的情况
Can Pharm J (Ott). 2025 Jan 24;158(2):77-80. doi: 10.1177/17151635241310878. eCollection 2025 Mar-Apr.
2
Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States.药师在美国管理高血压的处方的成本效益。
JAMA Netw Open. 2023 Nov 1;6(11):e2341408. doi: 10.1001/jamanetworkopen.2023.41408.
3
Stakeholders' Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review.利益相关者对社区药店药剂师主导筛查的可接受性：系统评价。
Am J Prev Med. 2022 Oct;63(4):636-646. doi: 10.1016/j.amepre.2022.04.023. Epub 2022 Jun 7.
4
Cost-effectiveness of pharmacist care for managing hypertension in Canada.加拿大药剂师管理高血压的成本效益分析
Can Pharm J (Ott). 2017 Mar 21;150(3):184-197. doi: 10.1177/1715163517701109. eCollection 2017 May-Jun.
5
Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.医疗保健干预措施的可接受性：综述概述及理论框架的构建
BMC Health Serv Res. 2017 Jan 26;17(1):88. doi: 10.1186/s12913-017-2031-8.
6
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.通过药剂师干预改善血压控制：随机对照试验的荟萃分析
J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718.
Zotero 插件